MedPath

Glucocorticoid-Induced Osteoporosis Treated with Bisphosphonate and Denosumab

Not Applicable
Conditions
Glucocorticoid-Induced Osteoporosis
Registration Number
JPRN-UMIN000014341
Lead Sponsor
Department of Connective Tissue Diseases, Tokyo Medical Center, National Hospital Organization
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

More than one year of bisphosphontes in 2 years before entry. Contraindication against bisphosphonates and denosumab.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Percent change in bone mineral density of the lumbar spine
Secondary Outcome Measures
NameTimeMethod
Safety, Incident vertebral fracture, bone mineral density of the femoral neck, bone makers
© Copyright 2025. All Rights Reserved by MedPath